Last reviewed · How we verify
N-acetylcysteine and ascorbic acid — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
N-acetylcysteine and ascorbic acid (N-acetylcysteine and ascorbic acid) — University of Thessaly.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| N-acetylcysteine and ascorbic acid TARGET | N-acetylcysteine and ascorbic acid | University of Thessaly | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- N-acetylcysteine and ascorbic acid CI watch — RSS
- N-acetylcysteine and ascorbic acid CI watch — Atom
- N-acetylcysteine and ascorbic acid CI watch — JSON
- N-acetylcysteine and ascorbic acid alone — RSS
Cite this brief
Drug Landscape (2026). N-acetylcysteine and ascorbic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/n-acetylcysteine-and-ascorbic-acid. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing